Lasa Supergenerics Limited — Board/Management Information 2021

Aug 21, 2021

Ref. No.: LASA/SE/21-22/26

Saturday August 21 2021

To,	To,
Corporate Services Department	Corporate Services Department
BSE Limited	National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers,	"Exchange Plaza", Plot No. C/1,
Dalal Street,	G Block Bandra-Kurla Complex,
Mumbai –400 001.	Bandra (E), Mumbai –400 051.
BSE CODE –540702	NSE CODE: LASA

Dear Sir/Madam,

Sub: Outcome of Board Meeting held today i.e. August 21, 2021

Pursuant to regulation 29 and regulation 30 of SEBI (Listing Obligation and discourse Requirement) Regulation 2015 we would like to inform you that the Board of Directors at their meeting held today which commenced at 12:00 noon and concluded at 2:45 p.m have considered and approved below:

1) Increase in authorised share capital of the company

Over the years, the volume of business has been increasing constantly and the company has also embarked upon expansion plans. In order to expand the capital base, it is now proposed to increase the authorised equity share capital from the existing limit of Rs.50,00,00,000/- (comprising 5,00,00,000 equity shares of Rs. 10/- each) to Rs.1,00,00,00,000/- (comprising 10,00,00,000 equity shares of Rs.10/- each).

• 2) The Date and time of the Sixth Annual General Meeting for the year ended March 31 2021.
• 3) The Notice of the Sixth Annual general Meeting (AGM) along with Directors report for the financial year 2020-21.
• 4) Appointment of Amit R. Dadheech and Associates, Practicing Company Secretaries as a scrutinizer for 6th Annual General Meeting.
• 5) Appointment of Mr. Shivanand hedge (DIN: 00185508) the Director who liable to retire by rotation and eligible for re-appointment.

• 6) Re-appointment of Independent directors of the company for second term of five years.
• 7) Re-appointment of Dr. Omkar Herlekar (DIN: 01587154) for the period of five years.
• 8) To close Register of Members and Share Transfer Books of the Company from Friday 17th September 2021 to Thursday 23th September 2021 both days inclusive.
• 9) To convene the Sixth Annual General Meeting of the Company on Friday, the 24th September 2021 through video conferencing/Other Audio Visual Means.

This Intimation is also available on the company's website at www.lasalabs.com and on the website of the stock Exchange at www.bseindia.com and www.nseindia.com.

This is for your information and record

YOURS TRULY, FOR LASA SUPERGENERICS LIMITED

NIDHI KULSHRESHTHA COMPANY SECRETARY AND COMPLIANCE OFFICER

LASA SUPERGENERICS LIMITED

Corporate Office : Office No. 705, Minerva Estate, Asha Nagar A Wing, O2 Commercial Tower, Mulund (West), Mumbai- 400 080 Email: info@lasalabs.com . Website: www.lasalabs.com

As required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 details of re-appointment of the aforesaid Directors are enclosed as an Annexure.

Name of Director	Dr. Omkar Pravin Herlekar	Mr. Shivananad Hegde
Director Identification No.	01587154	00185508
Date of Birth	March 13,1981	May 21, 1961
Date of appointment on Board	May 02,2017	May 02, 2017
Nationality	Indian	Indian
Qualifications	Doctorate in Philosophy (Science)from the Institute of ChemicalTechnology, Mumbai and a degree ofMasters of Science (By Research)(Theory) from University of Mumbai	Masters in Organic Chemistry
Expertise in specific functional areas	Dr. Omkar P. Herlekar is the Chairmanand Managing Director of LasaSupergenericsLimited.Uponassuming the leadership of Lasa, Dr.Herlekar charted a multi-prongedapproach for its corporate growth.Envisioning a global presence for thegroup, Dr. Herlekar played a pivotalrole in establishing marketing set-upacross and outside India. Lasa placesimmense focus on research. Dr.Herlekar has played a pivotal role inembryonic the group's 'CatalystChemistry' division that focuses ondevelopment of veterinary APIs andbreakthroughinnovations.Hiscontributions are widely acclaimed inthe industrycircles.Under hisleadership,Lasaachievednewoffered severalmilestonesandinnovations with the help of 'backwardintegration'. Herlekar's visionary andentrepreneurialleadershipastuteresulted in Lasa emerging as one of theanimalhealthcareleadingconglomerates in India, driven byresearch, and strategic thinking on aglobal scale. His clear vision, steadyguidance and boundless passion fororganic chemistry serve as catalysts forthe steady and continued expansion of	aged 60 years, is a Executive Directorof Lasa Supergenerics Limited (Lasa).He holds a degree of Masters ofScience (Final) in Organic ChemistryKarnatak University, Dharwad. He haspreviously worked as the VicePresident (Technical) at PI Drugs &Pharmaceuticals Limited, as the SeniorVice President (Operations) at D.K.Pharmachem Private Limited, as wellas the Vice President (Operations) atChemspec Chemicals Private Limited.Prior to joining Lasa, he was workingwith Lasa Laboratory Private Limitedas Executive Director. Pursuant to theScheme of Arrangement, his serviceswere transferred from Lasa LaboratoryPrivate Limited to Lasa effect fromMay 2, 2017.

LASA SUPERGENERICS LIMITED

Corporate Office : Office No. 705, Minerva Estate, Asha Nagar A Wing, O2 Commercial Tower, Mulund (West), Mumbai- 400 080

Email: info@lasalabs.com . Website: www.lasalabs.com

	the group.
	He also holds number of 'processpatents' to his credit. Dr. Herlekarspearheads business development,financialexpansioninitiatives,investmentmanagement,andregulatory affairs. He has a team ofexperienced technocrats whoarededicated towards scaling the group togreater heights through innovation andexcellence, thereby creating value forits stakeholders.
List of Directorships held in OtherCompanies (Excluding Foreign, Privateand Section 8 Companies)	N.A	N.A
Memberships/ Chairmanships of Audit	Membership $-1$ (One):- Member in	Membership-1 (One):- Member in
Stakeholders'Relationshipsand	Audit committee Lasa Supergenerics	Stakeholders'Relationship
Committees across Public Companies	Limited.	Committee of Lasa SupergenericsLimited.
Number of shares held in the	26222090 Equity shares	1000 Equity Shares
Company
Relationships between the Directors	N.A	N.A
inter-se

As required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 details of re-appointment of the aforesaid Independent Directors are enclosed as an Annexure.

Brief Profile of Non- Executive Independent directors:

• 1. Reason for Disclosures: : Re-appointment
• 2. Date of re- appointment: 1st May 2022
• 3. Term of Appointment: 5 years.
• 4. Brief profile:
• a) Mr. Hardesh Tolani

He is an Independent director of the company. He is chartered accountant by prof ession associated with leading f inancial institution. His area of expertise includes company audit f inancial reporting and taxation subject f ields. He has wide exposures in toll contracts bidding, f inancial modelling, operations of tolls booth, work ing of f ood processing units, and bank ing domain k nowledge.

b) Mr. Ajay Hareshlal Sukhwani

He is Independent director of the company. He holds bachelors of commerce degree from university of Mumbai. He is a Proprietor of tax consultancy firm based in Mumbai in the name of AJ Consultancy providing various services in taxation, insurance, statutory registration fields. He has around 14 years of experience in accounts, direct tax and indirect taxes.His expertise is in obtaining various statutory registrations in timely manner and appearing for assesement, Scrutiny and Appeals on client behalf.

c) Ms. Ekta Avtar Gurnasinghani

She is independent and women director of the company, she is a member of Institute of Chartered Accountant of India and holds master degree in commerce f rom Mumbai Univ ersity. She is hav ing 8 years of experience in the f ield of management f inancial reporting and consultancy.

5. Disclosure of re lationships be twe e n dire ctors:

No Independent direc tors have any relation w ith any member of the Board of Direc tors.

YOURS TRULY, FOR LASA SUPERGENERICS LIMITED

NIDHI KULSHRESHTHA COMPANY SECRETARY AND COMPLIANCE OFFICER